MedVi vs Ro.co: Compounded Semaglutide vs Wegovy Pill Choice
MedVi vs Ro.co is primarily a choice between compounded injectable semaglutide and an FDA-approved oral option. Early verdict: choose MedVi if you want a low promotional entry price and a no-clinic, compounded semaglutide program with 24/7 certified support; choose Ro.co if you need the FDA-approved Wegovy pill and prefer an oral, branded medication. The primary keyword MedVi vs Ro.co appears here to frame the comparison.
Start MedVi at its $179 winter promo
How the two platforms differ at a glance
MedVi and Ro.co differ most on pricing structure, medication type and regulatory status, clinical process and support, and whether medications are compounded or FDA-approved. Below are the most distinctive differences supported by the source material.
1. Price and promotional entry
MedVi advertises a winter promotional first-month price of starting at $179/month, which includes fast, free shipping. The evidence also notes ongoing standalone months can cost $299 and a three-month plan is $649. Ro.co highlights a low online entry point with Get Started Online for Just $39, while ongoing branded medication costs vary and can be higher.
Check MedVi pricing and promo details
2. Medication type and regulatory status
MedVi: clinically dosed compounded semaglutide. The source repeatedly states MedVi provides compounded semaglutide and also includes a regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co: offers the Wegovy pill, described as the first and only FDA-approved oral GLP-1; the source emphasizes that Ro is the only mainstream platform here offering access to the Wegovy pill, an FDA-approved finished product.
3. Clinical process and platform model
MedVi emphasizes a simple online process with no clinic visits needed and 24/7 support from certified medical professionals. Refills and clinician review are part of the MedVi program, and OpenLoop Health clinicians review eligibility and prescribe compounded GLP-1s at their discretion. Ro.co is presented as an established, full-service telehealth platform that prescribes FDA-approved medications after a licensed clinician review. Ro discloses pricing before consultation and is framed as better for patients who prefer regulatory clarity and brand-name products.
4. Who the platforms are best for
According to the sources: MedVi is best for patients who want the simplest path to compounded semaglutide therapy and a promotional first-month price. Ro.co is best for injection-averse patients or those who want an FDA-approved oral option and value brand trust and regulatory assurance.
Side-by-side comparison table
| Criteria | MedVi | Ro.co |
|---|---|---|
| Starting price | Starting at $179/month (winter promo, first month) | Get Started Online for Just $39 |
| Medication offered | Clinically dosed compounded semaglutide | Wegovy pill, FDA-approved oral GLP-1 |
| Regulatory note | Compounded medications are not FDA-approved | Wegovy pill is an FDA-approved finished medication |
| Clinical process | Simple online intake, no clinic visits, 24/7 certified support | Licensed clinician review on a full-service telehealth platform |
| Best for | Patients wanting simplest path to compounded semaglutide | Injection-averse patients wanting oral, FDA-approved option |
Detailed considerations
Price trajectory: MedVi’s promotional starting at $179/month is explicitly a first-month promo. The source states ongoing standalone months cost $299 and a three-month plan is $649, so the initial entry price may rise for refills. Ro.co’s $39 entry point is a direct-pay starting cost; the source says ongoing branded medication pricing depends on the plan and is often higher than compounded alternatives.
Medication choice and quality: MedVi offers compounded semaglutide produced in regulated facilities but the source reiterates compounded meds are not FDA-approved or individually reviewed by FDA for safety, effectiveness or quality. Ro.co supplies the Wegovy pill, an FDA-approved finished product, which the source presents as offering regulatory clarity compared with compounded injectables.
Explore Ro.co and the Wegovy pill
Support and process: MedVi highlights 24/7 certified medical support and a wholly online process with no clinic visits. Ro.co is described as an established telehealth provider that prescribes branded medications after clinician review and discloses pricing before consultation.
Start Ro.co with a $39 online visit
Conclusion and clear guidance
MedVi vs Ro.co comes down to whether you prioritize lower promotional entry and a streamlined, no-clinic compounded semaglutide program with 24/7 certified support or whether you prioritize an FDA-approved, oral Wegovy pill and branded regulatory assurance. MedVi offers compounded semaglutide starting at $179/month with no clinic visits and 24/7 support. Ro.co provides the FDA-approved Wegovy pill and an online start for $39.
Choose MedVi if you want a simple online intake, compounded semaglutide, and a winter promotional first-month price with 24/7 certified support.
Choose Ro.co if you prefer the FDA-approved Wegovy pill, an oral option to avoid injections, and a $39 online entry point with pricing disclosed before consultation.